SCHEMBL28005451

SCHEMBL28005451

CC(C)c1cc(C(C)C)c(-c2ccccc2P(=O)(OC2CCCCC2)OC2CCCCC2)c(C(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.44
ROCK2 O75116 1/20 0.40
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LMNA P02545 2/20 0.33
ALOX15 P16050 2/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
GLA P06280 1/20 0.31
MAPT P10636 2/20 0.30
HSD17B10 Q99714 1/20 0.30
POLB P06746 1/20 0.30
GPR84 Q9NQS5 2/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29485075 1.00 NPSR1 (0.44) NPSR1ROCK2MEN1KMT2AGAA
SCHEMBL1936383 0.81 ROCK2 (0.43) NPSR1ROCK2LMNAALDH1A1
SCHEMBL29933139 0.81 NPSR1 (0.43) NPSR1ROCK2MEN1KMT2AGAA
SCHEMBL19643364 0.77 NPSR1 (0.40) NPSR1MEN1KMT2AGAAL3MBTL1
SCHEMBL20605104 0.76 ROCK2 (0.48) NPSR1ROCK2MEN1KMT2AGAA
SCHEMBL28154606 0.76 PTPN5 (0.36)
SCHEMBL366679 0.76 MEN1 (0.41) NPSR1MEN1KMT2ALMNAALOX15
SCHEMBL28167753 0.75 GPR84 (0.44) NPSR1MEN1KMT2ALMNAALOX15
SCHEMBL31470225 0.75 GPR84 (0.44) NPSR1MEN1KMT2ALMNAALOX15
SCHEMBL25183137 0.74 PTPN5 (0.39) ROCK2GAAKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104478865-B For the substituted pyrimidine for the disease for treating such as cancer 勃林格殷格翰国际有限公司 2017-09-22 CN disclosed
CN-104478865-A Substituted pyrimidines for the treatment of diseases such as cancer BOEHRINGER INGELHEIM INT 2015-04-01 CN disclosed